PML and acute promyelocytic leukemia: The notable exception being acute promyelocytic leukemia (APL) with the development of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) to overcome the block in myeloid differentiation due to the PML-RARα fusion protein created by the translocation 15;17.